Montelukast
SINGULAIR
Leukotriene Receptor Antagonist
NADAC/unit
$0.0433
No Shortage
Tier 1: 173.3%
20 Manufacturers
46 ANDAs
Montelukast blocks leukotrienes to control asthma and allergic rhinitis symptoms.
vs. brand SINGULAIR: Generic saves up to 100% per unit
Active Shortages
2025-11-17 Discontinuation of the manufacture of the drug, Organon
Market Intelligence
2023-11-15 Class II Recall: Dr. Reddy's Laboratories, Inc.
2023-03-08 Class II Recall: Accord Healthcare, Inc.
Generic Manufacturers
ACCORD HEALTHCARE INCAJANTA PHARMA LTDAMNEAL PHARMACEUTICALSAMNEAL PHARMACEUTICALS OF NEW YORK LLCANBISON LABORATORY CO LTDAUROBINDO PHARMA LTDCHARTWELL MOLECULAR HOLDINGS LLCCIPLA LTDDR REDDYS LABORATORIES LTDGLENMARK PHARMACEUTICALS LTDHETERO LABS LTD UNIT VLANNETT CO INCMACLEODS PHARMACEUTICALS LTDORGANON LLC A SUB OF ORGANON AND COPHARMOBEDIENT CONSULTING LLCRISING PHARMA HOLDINGS INCSANDOZ INCSENORES PHARMACEUTICALS INCTEVA PHARMACEUTICALS USATORRENT PHARMACEUTICALS LTDUNICHEM LABORATORIES LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.